Department of Military Affairs Tender by Indian Army (GEM/2025/B/6195774)
Entecavir 0.5mg Tab,Duloxetine 20 mg Tab,Amisulpride 100 mg,Trimetazidine 35mg MR Tab,Dienogest 2 m

Tender Timeline
Tender Title: BOQDGLPCFARE95
Reference Number: GEM/2025/B/6195774
Issuing Authority/Department:
Department of Military Affairs, Ministry of Defence
Scope of Work and Objectives
The GEM/2025/B/6195774 tender focuses on the procurement of several pharmaceutical products, including Entecavir 0.5mg Tablets, Duloxetine 20mg Tablets, Amisulpride 100mg, Trimetazidine 35mg MR Tablets, and Dienogest 2mg Tablets. The objective is to secure a reliable supply of high-quality medications to support military health requirements. This procurement aims to ensure timely, standardized, and quality assurance of essential drugs.
Eligibility Criteria
To qualify for participation in this tender, bidders must meet the following eligibility requirements:
- Be a registered entity in India.
- Have previous experience in supplying pharmaceutical products to government organizations or healthcare facilities.
- Compliance with all relevant regulatory standards for the pharmaceutical industry.
Technical Requirements
Participants must provide products that meet stringent technical specifications and comply with quality control standards. Bidders are required to submit detailed product information, including:
- Evidence of compliance with Indian Pharmacopeia standards.
- Certificates of Good Manufacturing Practices (GMP).
Financial Requirements
Bidders must demonstrate financial stability through:
- Submission of financial statements for the last three years.
- Proof of the ability to fulfill the contract value, which involves handling the total quantity of 12,780 units.
Document Submission Details
Interested bidders must submit the required documents, including:
- Completed bidding forms.
- Technical and financial proposals.
- Relevant certificates and documentation to confirm eligibility and compliance.
Documents must be submitted in the specified format as outlined in the tender documentation.
Special Provisions
This tender has specific provisions for Micro, Small, and Medium Enterprises (MSEs). Bidders classified as MSEs are encouraged to apply and will receive preferential treatment during the evaluation process. Additionally, there are provisions to encourage participation from startups, fostering innovation in providing pharmaceutical solutions.
Evaluation Process
The evaluation process for this tender will focus on technical compliance, financial stability, and relevant experience. Bidders will be assessed based on:
- Quality standards of offered products.
- Adherence to technical specifications.
- Overall cost- effectiveness and value for money.
Delivery Locations
The successful bidder will be required to deliver the products to designated military medical facilities as specified upon contract award.
Contact Information
For further inquiries regarding the tender, bidders are encouraged to refer to the official channels provided in the tender documentation for clarification on any submitted queries.
This tender aims to enhance the healthcare provisions for military personnel and ensure accessibility to vital medications.
Tender BOQ Items
5 ItemsGeneral Information
Financial Information
Evaluation and Technical Information
Tender Documents
6 DocumentsDocuments Required from Seller
- Experience Criteria
- Bidder Turnover
- Certificate (Requested in ATC)
- OEM Authorization Certificate
- OEM Annual Turnover
- Compliance of BoQ specification and supporting document *In case any bidder is seeking exemption from Experience / Turnover Criteria
- the supporting documents to prove his eligibility for exemption must be uploaded for evaluation by the buyer
Similar Tenders
Frequently Asked Questions
The eligibility requirements include being a registered entity, having prior experience in supplying pharmaceutical products to the government, and ensuring compliance with all relevant regulatory standards in the pharmaceutical industry. It is critical that applicants can provide proper documentation confirming their experience and registration.
Bidders must provide several essential certificates to support their application, including proof of Good Manufacturing Practices (GMP), compliance with Indian Pharmacopeia standards, and financial statements for the past three years. These documents validate the suppliers’ ability to meet the tender’s quality and technical specifications.
The registration process involves filling out the required bidding forms and submitting necessary documentation like experience letters, financial statements, and compliance certificates as part of the tender submission. Ensure to follow the detailed submission guidelines in the tender document carefully.
The payment terms generally require advance payments or milestone-based payments upon successful delivery of the products. Additionally, a performance security deposit may be required, typically around 10% of the contract value, which will be released upon successful completion of the contract.
Yes, the GEM/2025/B/6195774 tender provides special provisions for MSEs, including price preference during evaluation and a simplified documentation process. MSEs are encouraged to engage in this tender to foster competition and enhance participation, thereby stimulating economic growth and innovation.
This structured content provides an SEO-optimized overview of the GEM/2025/B/6195774 tender, providing essential information in a reader-friendly manner while incorporating relevant keywords for visibility.
Probable Bidders
Get Tender Alerts
Get notifications for similar tenders